{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-26-092730","form_type":"8-K","ticker":"CERT","cik":"0001827090","company_name":"Certara, Inc.","filed_at":"2026-08-07T20:20:22+00:00","discovered_at":"2026-08-07T20:21:00.401078+00:00","generated_at":"2026-08-07T20:21:04.540722+00:00","sec_items":["7.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"Certara corrects Q2 2026 call misstatement on divested business's 2025 adjusted EBITDA","bullets":["Corrected 2025 adjusted EBITDA for divested Regulatory and Medical Writing business: ~$17M including unallocated overhead costs, not excluding.","Excluding unallocated corporate expense that remains with Certara, 2025 adjusted EBITDA is ~$23M.","Misstatement appeared on Aug 4, 2026 earnings call and Q2 2026 presentation; updated presentation posted to ir.certara.com.","Clarification has no impact on previously reported results, year-over-year comparisons, or 2026 Financial Outlook."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-26-092730","json":"https://secwatch.observer/filing/0001104659-26-092730.json","markdown":"https://secwatch.observer/filing/0001104659-26-092730.md","text":"https://secwatch.observer/filing/0001104659-26-092730.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1827090/000110465926092730/0001104659-26-092730-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1827090/000110465926092730/tm2622458d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-08-07T20:21:04.540722+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}